Rhythm Pharmaceuticals, Inc. (RYTM)
96.06
-2.41
(-2.45%)
USD |
NASDAQ |
Feb 12, 16:00
96.76
+0.70
(+0.73%)
Pre-Market: 09:28
Rhythm Pharmaceuticals Free Cash Flow : -149.13M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Gilead Sciences, Inc. | 10.02B |
| Johnson & Johnson | 19.70B |
| Eli Lilly & Co. | 6.436B |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Geron Corp. | -132.68M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -26.62M |
| Cash from Investing (Quarterly) | -246.35M |
| Cash from Financing (Quarterly) | 189.30M |
| Free Cash Flow Per Share (Quarterly) | -1.005 |
| Free Cash Flow to Equity (Quarterly) | -67.12M |
| Free Cash Flow to Firm (Quarterly) | -61.87M |
| Free Cash Flow Yield | -2.44% |